刘群，女，博士，副教授，硕士研究生导师。2014年毕业于中国药科大学生药学专业，获博士学位。同年7月加入中国药科大学中药学院及天然药物活性组分与药效国家重点实验室。哈佛医学院丹娜法伯癌症研究中心访问****。
一直致力于糖尿病、肥胖等代谢性疾病的发病机制及中药干预作用研究。作为课题负责人，先后主持国家自然科学面上基金（**）、青年基金（**）、江苏省青年基金（BK**）、中央高校基本科研业务项目等纵向课题4项，主持横向课题3项。近五年在Nature Communications, Theranostics, British Journal of Pharmacology, Molecular Cancer等杂志参与发表SCI论文20余篇。承担《生药学》课程的理论与实验教学，参与编写《生药学》教材。AJCM, Frontiers Physiology杂志同行审稿人。
主要研究方向：（1）中药干预代谢性疾病分子机制研究；（2）基于组学技术发现中药干预复杂性疾病的作用特点。
代表性论文：
1. Zhang Wen-Song, Pan An, Zhang Xu, Ying Ang, Ma Gao-Xiang, Liu Bao-Lin, Qi Lian-Wen*, Liu Qun*, Li Ping*, Inactivation of NF-κB2 (p52) restrains hepatic glucagon response via preserving PDE4B induction. Nature Communications2019, 2019, 20;10(1):4303.
2. Liu Qun¹, Zhang Fei-Ge¹, Zhang Wen-Song, Pan An, Yang Yi-Lin, Liu Jin-Feng, Li Ping, Liu Bao-Lin, Qi Lian-Wen*, Ginsenoside Rg1 inhibits glucagon-induced hepatic gluconeogenesis through Akt-FoxO1 interaction. Theranostics2017, 7(16): 4001-4012.
3. Lou Meng-Die¹, Li Jia¹, Cheng Yao, Xiao Na, Ma Gao-Xiang, Li Ping, Liu Bao-Lin, Liu Qun*, Qi Lian-Wen*. Glucagon up-regulates hepatic mitochondrial pyruvate carrier 1 through cAMP-responsive element-binding protein; inhibition of hepatic gluconeogenesis by ginsenoside Rb1. British Journal of Pharmacology2019, 176(16):2962-2976.
4. Liu Qun¹, Peng Yong-Bo¹, Zhou Ping, Qi Lian-Wen, Zhang Mu, Gao Ning*, Liu E-Hu* and Li Ping*, 6-Shogaol induces apoptosis in human leukemia cells through a process involving caspase-mediated cleavage of eIF2α. Molecular Cancer2013, 12:135.
5. Ying Ang, Yu Qing-Tao, Guo Li, Zhang Wen-Song, Liu Jin-Feng, Li Yun, Song Hong, Li Ping, Qi Lian-Wen, Ge Ya-Zhong*, Liu E-Hu*, Liu Qun*, Structural-Activity Relationship of Ginsenosides from Steamed Ginseng in the Treatment of Erectile Dysfunction. The American Journal of Chinese Medicine 2018, 46(1):137-155.
联系方式：liuquncpu@126.com